author-photo

Yan Jia

Eisai

4

Papers

16

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus pegylated liposomal doxorubicin (PLD) in women with low CA-125 platinum-sensitive ovarian cancer

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study

2019 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (7)